ARCHIVES

Phase III Cyramza Trial Meets OS Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Lobuglio Named Alabama Comprehensive Center Director; NCI FY 1983 Funds Will Be $983.6 Million

January 7, 1983

Bladder Cancer “Headquarters” Grant Program Seeks Applications For High Priority Research

March 1, 1974

In Brief: Walter Lawrence, Reginald Ho Lead ACS; Henderson To Leave Dana-Farber for UCSF

November 22, 1991

New CIS Regions Draw Support, Some Objections

July 5, 1991

U.S. Tobacco Program Loses $505 il. In Loan Principle, Report Finds

January 5, 1990

CMF Studies Show Higher Recurrence for Post-Menopausal Patients – Caldwell

November 12, 1976